CA
ZBH icon

CXI Advisors’s Zimmer Biomet ZBH Stock Holding History

CXI Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Buy
+11
New +$1.52K ﹤0.01% 197

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

CXI Advisors's ZBH Position: Q4 2019 in Review

CXI Advisors opened a new position in Zimmer Biomet (ZBH) in Q4 2019: 11 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #197 among its holdings.

990 funds tracked by Wall St. Rank hold ZBH as of Q4 2019.

  • CXI Advisors held 11 shares of Zimmer Biomet worth $2K as of Q4 2019.
  • Zimmer Biomet was a new CXI Advisors position in Q4 2019.
  • Zimmer Biomet made up ﹤0.01% of CXI Advisors's portfolio in Q4 2019, its #197 holding.
  • 990 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2019.

Based on CXI Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.